Model Number V254 - V260 |
Device Problem
Application Program Problem: Medication Error (3198)
|
Patient Problems
Skin Irritation (2076); Torsades-de-Pointes (2107); Electrolyte Imbalance (2196)
|
Event Date 06/06/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
Cerner distributed a priority review flash notification flash19-0421-0 on june 28, 2019 to all potentially impacted client sites.The software notification includes a description of the issue and notice that a software modification is being developed to address the issue for all sites that could potentially be impacted. cerner corporation will provide a follow-up report when the software modification is available.
|
|
Event Description
|
The software product mentioned in this medwatch report may not be, by definition, a medical device; however, cerner has chosen to file this medwatch report in order to voluntarily notify the fda of a malfunction associated with this software product. the company's filing of this medwatch report does not signify cerner's belief or understanding that medical device reports are required to be filed for products such as cerner's multum®, nor are these products currently actively regulated by the fda. this report documents information related to an issue identified with functionality included in cerner's multum® drug content. the issue involves cerner multum® and affects users that utilize drug content for drug interaction checking. new drug numbers were created for the drugs suprep and gleolan and drug interaction checks were either omitted or incorrectly categorized.As a result, there is a potential that drug interaction alerts may not display when prescribing these medications. patient care could be adversely affected, as clinicians may prescribe incompatible drugs resulting in adverse reaction.This issue could result in serious injury to the patient.Cerner has not received communication on any adverse patient events as a result of this issue. .
|
|
Manufacturer Narrative
|
Cerner distributed a priority review flash notification flash19-0421-1 on july 8, 2019 to all potentially impacted client sites.The software notification includes a description of the issue and notice that a software modification has been developed to address the issue for all sites that could potentially be impacted.Cerner corporation considers this issue to be resolved and no further narrative is required for follow-up.
|
|
Event Description
|
The software product mentioned in this medwatch report may not be, by definition, a medical device; however, cerner has chosen to file this medwatch report in order to voluntarily notify the fda of a malfunction associated with this software product.The company's filing of this medwatch report does not signify cerner's belief or understanding that medical device reports are required to be filed for products such as cerner's multum®, nor are these products currently actively regulated by the fda.This report documents information related to an issue identified with functionality included in cerner's multum® drug content.The issue involves cerner multum® and affects users that utilize drug content for drug interaction checking.New drug numbers were created for the drugs suprep and gleolan and drug interaction checks were either omitted or incorrectly categorized.As a result, there is a potential that drug interaction alerts may not display when prescribing these medications.Patient care could be adversely affected, as clinicians may prescribe incompatible drugs resulting in adverse reaction.This issue could result in serious injury to the patient.Cerner has not received communication on any adverse patient events as a result of this issue.
|
|
Search Alerts/Recalls
|